Drug recall · January 4, 2017
Nadolol Tablets recall
Why: Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10
- Lots / codes
Lot GG1539
- Quantity
- 96 bottles
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- MS and OH.
- Initiated
- December 22, 2016 · Voluntary: Firm initiated
- Classified
- December 27, 2016
- Reported
- January 4, 2017
- Ended
- September 18, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nadolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.